17 alpha-hydroxyprogesterone caproate has been researched along with thymic factor, circulating in 1 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (thymic factor, circulating) | Trials (thymic factor, circulating) | Recent Studies (post-2010) (thymic factor, circulating) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 234 | 12 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhidze, EV | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and thymic factor, circulating
| Article | Year |
|---|---|
Application of thymic factor "Thymalin" in complex treatment of endometrial cancer patients.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adjuvants, Immunologic; Antineoplastic Agents; Cells, Cultured; Combined Modality Therapy; Estradiol; Female; Humans; Hydroxyprogesterones; Immunity, Cellular; Middle Aged; Rosette Formation; Survival Rate; T-Lymphocyte Subsets; Tamoxifen; Thymus Hormones; Uterine Neoplasms | 1990 |